Akebia Therapeutics (AKBA) Revenue (2013 - 2026)
Akebia Therapeutics (AKBA) revenue from Mar 31, 2013 to Mar 31, 2026. The TTM Akebia Therapeutics (AKBA) revenue is $232M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Akebia Therapeutics (AKBA) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +25.68% |
| 3 Years TTM | -4.97% |
| 5 Years TTM | -2.15% |
Annual Revenue change of Akebia Therapeutics (AKBA)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $54M | -77.33% |
| 2025 | $236M | +47.46% |
| 2024 | $160M | -17.70% |
| 2023 | $195M | -33.46% |
| 2022 | $292M | +36.94% |
| 2021 | $214M | -27.68% |
| 2020 | $295M | -11.85% |
| 2019 | $335M | +61.26% |
| 2018 | $208M | +14.63% |
| 2017 | $181M | +11668.18% |
| 2016 | $1.54M | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
Comparison Akebia Therapeutics (AKBA) five years revenue CAGR with competitors
Akebia Therapeutics (AKBA) five years revenue CAGR is -2.15%.